Search for Clinical Trial Results

Sponsored By

Hemangioendothelioma - 17 Studies Found

Status Study
Recruiting Study Name: Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery
Condition: Epithelioid Hemangioendothelioma
Date: 2017-05-01
Interventions:
  • Other: Laboratory Biomarker Analysis

Recruiting Study Name: A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Condition:
  • Kaposiform Hemangioendothelioma (KHE)
  • Kasabach-Merritt Syndrome
    Date: 2014-04-08
    Interventions:
    • Drug: Vincristine Vincristine

Not yet recruiting Study Name: Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization.
Condition:
  • Congenital Hemangioma
  • Hemangioendothelioma
  • Vascular Anomaly
  • Generalized Lymphatic Anomaly
  • Kaposiform
    Date: 2016-12-15
Recruiting Study Name: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma
Condition:
  • Adult Alveolar Soft Part Sarcoma
  • Adult Angiosarcoma
  • Adult
    Date: 2012-02-06
    Interventions:
    • Drug: Gemcitabine Hydrochloride

Completed Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Condition:
  • Adult Alveolar Soft Part Sarcoma
  • Adult Angiosarcoma
  • Adult
    Date: 2010-06-29
    Interventions:
    • Drug: Gamma-Secretase Inhibitor RO4929097

Active, not recruiting Study Name: Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Condition:
  • Kaposiform Hemangioendotheliomas
  • Tufted Angioma
  • Date: 2009-09-10
    Interventions: Drug: sirolimus liquid dosing based on trough levels
Recruiting Study Name: Lymphatic Anomalies Registry
Condition:
  • Lymphatic Malformation
  • Generalized Lymphatic Anomaly (GLA)
  • Date: 2015-03-17
Recruiting Study Name: Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes
Condition: Advanced and/or Metastatic Sarcoma
Date: 2016-06-16
Interventions:
  • Drug: Durvalumab Age group 
Recruiting Study Name: Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery
Condition: Epithelioid Hemangioendothelioma
Date: 2017-05-01
Interventions:
  • Other: Laboratory Biomarker Analysis

Next >>>